Family-focused Literacy Strategies for Heart Failure
(FamLit_HF Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new approach to help people with heart failure adhere to their medication routines. Nurses will use simple language to coach patients and their care partners, aiming to improve medication adherence, reduce hospital visits, and enhance quality of life. The trial involves two groups: one receives the new coaching method called the Family-focused and Literacy-sensitive Intervention (FamLit), and the other receives standard attention. It suits those with heart failure who struggle with taking their medications as prescribed and have someone who regularly assists with their care. As an unphased trial, this study offers a unique opportunity to contribute to innovative strategies that could significantly improve patient care.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, it mentions that participants should have been on stable doses of heart failure medications for at least 3 months, suggesting you may need to continue your current medications.
What prior data suggests that this intervention is safe for heart failure patients and their care partners?
Research has shown that health literacy programs, like the one in this trial, are generally safe. Studies suggest that efforts to improve understanding of heart failure and medication use pose no physical risks. Instead, they often help patients manage their conditions better.
Past studies reported no negative effects directly linked to these educational programs. These programs aim to provide simple, clear information to help people take their medicine as prescribed and improve their overall quality of life.
While evidence shows no safety concerns, discussing any questions with the trial team is always a good idea to ensure comfort and understanding.12345Why are researchers excited about this trial?
Researchers are excited about the FamLit approach because it introduces family-focused literacy strategies to support heart failure management. Unlike traditional treatments that primarily involve medication or lifestyle changes, FamLit emphasizes education and communication among patients and their care partners. This method aims to enhance understanding and management of the condition by improving health literacy, which could lead to better adherence to treatment plans and overall outcomes. By involving family members, this approach fosters a supportive environment, potentially reducing hospital readmissions and improving quality of life for patients.
What evidence suggests that this trial's interventions could be effective for heart failure?
Research has shown that the FamLit program, one of the interventions in this trial, emphasizes family involvement and clear communication to help patients with heart failure take their medication more consistently. Studies have found that patients in such programs develop better medication-taking habits. This is crucial because adhering to prescribed medication can reduce hospital visits and enhance the quality of life for heart failure patients. By involving family members and using simple language, the program aids patients in following their medication plans more reliably. This approach has shown promise in supporting long-term medication use and reducing heart failure complications. Meanwhile, the trial will evaluate the Attention Control intervention, another arm of this study, for its comparative effectiveness.678910
Who Is on the Research Team?
Jia-Rong Wu
Principal Investigator
University of Kentucky
Are You a Good Fit for This Trial?
This trial is for adults with heart failure who've been on stable heart medication for at least 3 months, can manage their own meds, and have a care partner involved in their care. Participants must be willing to use an electronic pillbox and attend coaching sessions. Excluded are those with terminal illnesses, substance abuse issues, recent hospitalizations, communication barriers or cognitive impairments.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Initial assessment and randomization of participants into intervention or control groups
Intervention
FamLit intervention or attention-control group sessions focusing on medication adherence or general health issues
Follow-up
Participants are monitored for medication adherence, hospitalization, and quality of life
What Are the Treatments Tested in This Trial?
Interventions
- Attention Control
- FamLit
Find a Clinic Near You
Who Is Running the Clinical Trial?
Jia-Rong Wu
Lead Sponsor
National Institute of Nursing Research (NINR)
Collaborator